Alexander Streuer

5PUBLICATIONS
20CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical infection agents (incl. prions)Phylogeny and comparative analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 30, 2026
Dose-Adjusted Treatment With 7-Day Venetoclax Plus Azacitidine or Decitabine in Patients With Acute Myeloid Leukaemia.

|Dec 23, 2025
Dynamic Mortality Risk Prediction in Myelodysplastic Syndromes Using Longitudinal Clinical Data.

Jonathan Bobak, Philipp Spohr, Sarah Richter

|Aug 21, 2025
The bispecific innate cell engager AFM28 eliminates CD123+ leukemic stem and progenitor cells in AML and MDS.

Nanni Schmitt, Jana-Julia Siegler, Alexandra Beck

|Mar 18, 2023
Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies.

Qingyu Xu, Alexander Streuer, Johann-Christoph Jann

|Jul 30, 2020
RNA-sequencing of acute promyelocytic leukemia primary blasts reveals novel molecular biomarkers of early death events.

Johann-Christoph Jann, Alexander Streuer, Anna Hecht

Pageof 1

Frequent Collaborators

4 joint publications

Nanni Schmitt

2 joint publications

Daniel Nowak

1 joint publications

Johann-Christoph Jann

1 joint publications

Eva Lengfelder